HomeAKTX • NASDAQ
add
Akari Therapeutics PLC
Previous close
$5.31
Day range
$4.45 - $5.50
Year range
$4.45 - $63.20
Market cap
5.32M USD
Avg Volume
10.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.23M | -24.87% |
Net income | -5.30M | -40.46% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.22M | 24.93% |
Effective tax rate | -1.63% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.20M | 100.19% |
Total assets | 47.89M | -5.28% |
Total liabilities | 19.56M | -30.95% |
Total equity | 28.33M | — |
Shares outstanding | 1.14M | — |
Price to book | 0.21 | — |
Return on assets | -17.30% | — |
Return on capital | -29.89% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.30M | -40.46% |
Cash from operations | -3.04M | -43.17% |
Cash from investing | — | — |
Cash from financing | 5.76M | 167.41% |
Net change in cash | 2.72M | 558.35% |
Free cash flow | -6.54M | -195.43% |
About
Founded
2004
Headquarters
Website
Employees
9
